GB1377327A - Ethers of n-propanolamine and preparation thereof - Google Patents
Ethers of n-propanolamine and preparation thereofInfo
- Publication number
- GB1377327A GB1377327A GB1037973A GB1037973A GB1377327A GB 1377327 A GB1377327 A GB 1377327A GB 1037973 A GB1037973 A GB 1037973A GB 1037973 A GB1037973 A GB 1037973A GB 1377327 A GB1377327 A GB 1377327A
- Authority
- GB
- United Kingdom
- Prior art keywords
- phenyl
- group
- isobutyl
- general formula
- propanolamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 title abstract 3
- 150000002170 ethers Chemical class 0.000 title abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 abstract 2
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 2
- 125000001302 tertiary amino group Chemical group 0.000 abstract 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000001414 amino alcohols Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 abstract 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 abstract 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000005669 field effect Effects 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 150000003840 hydrochlorides Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000005936 piperidyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7207647A FR2174655B1 (enExample) | 1972-03-06 | 1972-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1377327A true GB1377327A (en) | 1974-12-11 |
Family
ID=9094658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1037973A Expired GB1377327A (en) | 1972-03-06 | 1973-03-02 | Ethers of n-propanolamine and preparation thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US3962238A (enExample) |
| JP (1) | JPS4899127A (enExample) |
| BE (1) | BE795735A (enExample) |
| CA (2) | CA1015360A (enExample) |
| CH (1) | CH556815A (enExample) |
| DE (1) | DE2310918C3 (enExample) |
| ES (1) | ES412203A1 (enExample) |
| FR (1) | FR2174655B1 (enExample) |
| GB (1) | GB1377327A (enExample) |
| IL (1) | IL41619A (enExample) |
| NL (1) | NL153190C (enExample) |
| ZA (1) | ZA731411B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0237191A1 (en) * | 1986-02-12 | 1987-09-16 | McNeilab, Inc. | 3-alkoxy-2-aminopropylamines useful as cardiovascular agents |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2378024A1 (fr) * | 1977-01-25 | 1978-08-18 | Cerm Cent Europ Rech Mauvernay | Nouvelle propylamine substituee, obtention et application |
| FR2472567A1 (fr) | 1979-12-28 | 1981-07-03 | Cerm Cent Europ Rech Mauvernay | Ethers de 1- (2-propynyloxy)-2-amino-3-propanol, leur preparation et leur application en therapeutique |
| AU559555B2 (en) * | 1981-12-28 | 1987-03-12 | Carter-Wallace, Inc. | Chemical process |
| US4405580A (en) * | 1982-01-18 | 1983-09-20 | Exxon Research And Engineering Co. | Process for selective removal of H2 S from mixtures containing H22 with tertiary amino azabicyclic alcohols |
| US4405582A (en) * | 1982-01-18 | 1983-09-20 | Exxon Research And Engineering Co. | Process for selective removal of H2 S from mixtures containing H22 using diaminoether solutions |
| US4417075A (en) * | 1982-01-18 | 1983-11-22 | Exxon Research And Engineering Co. | Di-(Secondary and tertiaryalkylaminoalkoxy)alkanes |
| US4405581A (en) * | 1982-01-18 | 1983-09-20 | Exxon Research And Engineering Co. | Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary amino compounds |
| US4405583A (en) * | 1982-01-18 | 1983-09-20 | Exxon Research And Engineering Co. | Process for selective removal of H2 S from mixtures containing H22 using di-severely sterically hindered secondary aminoethers |
| US4471138A (en) * | 1982-01-18 | 1984-09-11 | Exxon Research And Engineering Co. | Severely sterically hindered secondary aminoether alcohols |
| US4483833A (en) * | 1982-01-18 | 1984-11-20 | Exxon Research & Engineering Co. | Process for selective removal of H2 S from mixtures containing H22 with heterocyclic tertiary aminoalkanols |
| US4405811A (en) * | 1982-01-18 | 1983-09-20 | Exxon Research And Engineering Co. | Severely sterically hindered tertiary amino compounds |
| US4405585A (en) * | 1982-01-18 | 1983-09-20 | Exxon Research And Engineering Co. | Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary aminoether alcohols |
| US4762934A (en) * | 1982-01-18 | 1988-08-09 | Exxon Research And Engineering Company | Diaminoether compositions |
| US4508692A (en) * | 1982-01-18 | 1985-04-02 | Exxon Research & Engineering Co. | Process for the selective removal of hydrogen sulfide from gaseous mixtures with strongly basic tertiary amino compounds |
| DK156396C (da) * | 1983-09-27 | 1990-01-08 | Cerm Cent Europ Rech Mauvernay | 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse |
| GB8330197D0 (en) * | 1983-11-11 | 1983-12-21 | Akzo Nv | Ether of n-propanolamine derivative |
| AU568704B2 (en) * | 1983-11-11 | 1988-01-07 | Akzo N.V. | Ether of n-propanolamine derivative |
| US4758563A (en) * | 1986-02-12 | 1988-07-19 | Mcneilab, Inc. | 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use |
| DE3726633A1 (de) * | 1987-08-11 | 1989-02-23 | Boehringer Mannheim Gmbh | Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
| DE3726632A1 (de) * | 1987-08-11 | 1989-05-18 | Boehringer Mannheim Gmbh | 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten |
| US4888335A (en) | 1988-07-25 | 1989-12-19 | Mcneilab, Inc. | 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents |
| US5185362A (en) * | 1988-09-14 | 1993-02-09 | Mcneilab, Inc. | Diphenylamine cardiovascular agents, compositions and use |
| RS20050106A (sr) | 2002-08-19 | 2007-11-15 | Pfizer Products Inc., | Kombinovana terapija hiperproliferativnih bolesti |
| BRPI0410840A (pt) * | 2003-05-30 | 2006-07-04 | Ranbaxy Lab Ltd | derivados substituìdos de pirrol, composição farmacêutica contendo os mesmos e processo para sua preparação |
| US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
| CN101090714A (zh) * | 2004-07-26 | 2007-12-19 | 康泽里克斯公司 | 通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症 |
| CA2590533C (en) * | 2004-11-23 | 2010-09-07 | Warner-Lambert Company Llc | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| EP2351569B1 (en) | 2005-10-26 | 2012-08-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| ATE551059T1 (de) * | 2005-10-26 | 2012-04-15 | Asahi Kasei Pharma Corp | Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie |
| JP2009514851A (ja) * | 2005-11-08 | 2009-04-09 | ランバクシー ラボラトリーズ リミテッド | （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法 |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
| AR059838A1 (es) * | 2006-03-14 | 2008-04-30 | Ranbaxy Lab Ltd | Formulaciones para dosis estabilizantes de estatina |
| MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
| ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
| US8748648B2 (en) | 2007-09-06 | 2014-06-10 | Nektar Therapeutics | Oligomer-calcium channel blocker conjugates |
| US8883844B2 (en) | 2010-09-24 | 2014-11-11 | Nitrogenix Inc. | Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions |
| MX2015014666A (es) | 2013-04-17 | 2016-03-01 | Pfizer | Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares. |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| WO2016098128A1 (en) | 2014-12-16 | 2016-06-23 | Council Of Scientific & Industrial Research | Process for the preparation of bepridil |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH268689A (de) * | 1947-07-01 | 1950-05-31 | Spojene Farmaceuticke Z Narodn | Verfahren zur Darstellung eines biologisch wirksamen Phenyläthylendiaminderivates. |
| US2600301A (en) * | 1948-06-04 | 1952-06-10 | Smith Kline French Lab | N-substituted-beta halo-ethyl amines |
| BE546290A (enExample) * | 1955-04-09 | |||
| GB1219609A (en) * | 1968-07-19 | 1971-01-20 | Koninklijke Pharma Fab Nv | Diphenylmethoxyethylamino derivatives |
-
0
- BE BE795735D patent/BE795735A/xx unknown
-
1972
- 1972-03-06 FR FR7207647A patent/FR2174655B1/fr not_active Expired
-
1973
- 1973-02-20 CH CH270373A patent/CH556815A/fr not_active IP Right Cessation
- 1973-02-26 IL IL41619A patent/IL41619A/en unknown
- 1973-02-27 US US05/336,357 patent/US3962238A/en not_active Expired - Lifetime
- 1973-02-28 ZA ZA731411A patent/ZA731411B/xx unknown
- 1973-03-01 ES ES412203A patent/ES412203A1/es not_active Expired
- 1973-03-01 JP JP48024754A patent/JPS4899127A/ja active Pending
- 1973-03-02 GB GB1037973A patent/GB1377327A/en not_active Expired
- 1973-03-05 DE DE2310918A patent/DE2310918C3/de not_active Expired
- 1973-03-06 NL NL7303117.A patent/NL153190C/xx not_active IP Right Cessation
- 1973-03-06 CA CA165,544A patent/CA1015360A/fr not_active Expired
-
1978
- 1978-05-30 CA CA304,367A patent/CA1048027A/fr not_active Expired
-
1979
- 1979-02-27 US US06/015,752 patent/USRE30577E/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0237191A1 (en) * | 1986-02-12 | 1987-09-16 | McNeilab, Inc. | 3-alkoxy-2-aminopropylamines useful as cardiovascular agents |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2310918A1 (de) | 1973-09-20 |
| FR2174655A1 (enExample) | 1973-10-19 |
| ZA731411B (en) | 1974-04-24 |
| FR2174655B1 (enExample) | 1975-08-01 |
| ES412203A1 (es) | 1975-12-01 |
| NL7303117A (enExample) | 1973-09-10 |
| CA1015360A (fr) | 1977-08-09 |
| DE2310918C3 (de) | 1980-07-03 |
| IL41619A0 (en) | 1973-04-30 |
| DE2310918B2 (de) | 1979-10-25 |
| USRE30577E (en) | 1981-04-14 |
| IL41619A (en) | 1976-05-31 |
| BE795735A (fr) | 1973-06-18 |
| CH556815A (fr) | 1974-12-13 |
| NL153190B (nl) | 1977-05-16 |
| US3962238A (en) | 1976-06-08 |
| JPS4899127A (enExample) | 1973-12-15 |
| NL153190C (nl) | 1980-12-15 |
| CA1048027A (fr) | 1979-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1377327A (en) | Ethers of n-propanolamine and preparation thereof | |
| GB1409693A (en) | Triazolobenzodiazepines | |
| GB1467927A (en) | Derivatives of tyrosine having a pharmaceutical activity on smooth muscles | |
| GB1117625A (en) | Substituted phthalans | |
| GB1380129A (en) | Benzofuran derivatives and preparation thereof | |
| GB1187259A (en) | New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture | |
| JPS5632474A (en) | Piperazine derivative and its preparation | |
| GB1282600A (en) | Basic aryloxyacetamides | |
| ATE27813T1 (de) | N-substituierte 1-(4'-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate. | |
| GB1363195A (en) | Propenylamine derivatives and process for the production thereof | |
| GB1176757A (en) | Quinuclidine Carboxylic Acid Amides | |
| GB1225462A (enExample) | ||
| GB1392908A (en) | Salts thereof | |
| GB1443692A (en) | 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof | |
| GB1453417A (en) | Nitroimidazoles | |
| GB1174880A (en) | Derivatives of alpha-Piperazinophenylacetonitrile and process for manufacture of same | |
| GB1268469A (en) | Halomethylquinolylamino-benzamides | |
| GB1440834A (en) | Esters and amides for 3-aryl-1,4-benzodioxan-2-carboxylic acids | |
| GB1377610A (en) | 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof | |
| GB1457005A (en) | 2-substituted-3-aminoquinoxalines | |
| GB1223062A (en) | Improvements in or relating to new aminoacid derivatives | |
| GB1391837A (en) | Method of inducing infertility and preventing littering in the female | |
| GB1261004A (en) | Ketones derived from -1-(2-hydroxyethyl)-piperazine | |
| GB1420560A (en) | S-i-v-benzo-1,2,4-thiadiazines | |
| GB1351412A (en) | Method of inducing infertility in the male and inhibiting the growth of the prostrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 429A | Application made for amendment of specification (sect. 29/1949) | ||
| 429H | Application (made) for amendment of specification now open to opposition (sect. 29/1949) | ||
| 429D | Case decided by the comptroller ** specification amended (sect. 29/1949) | ||
| SPA | Amended specification published | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19930301 |